Grace Chazan

Parkville, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Treatment Patterns, Prognostic Factors and Survival for ALK-Positive Advanced NSCLC In Australia: Results From the Australasian Thoracic Cancers Longitudinal Cohort Study and Biobank (AURORA).

Treatment Patterns, Prognostic Factors and Survival for ALK-Positive Advanced NSCLC In Australia: Results From the Australasian Thoracic Cancers Longitudinal Cohort Study and Biobank (AURORA).

Journal: JTO clinical and research reports

Published: June 06, 2025

Real-World Treatment and Outcomes in ALK-Rearranged NSCLC: Results From a Large U.S.-Based Database.

Real-World Treatment and Outcomes in ALK-Rearranged NSCLC: Results From a Large U.S.-Based Database.

Journal: JTO clinical and research reports

Published: September 30, 2023

Optimal first-line treatment for metastatic ALK+ non-small cell lung cancer-a narrative review.

Optimal first-line treatment for metastatic ALK+ non-small cell lung cancer-a narrative review.

Journal: Translational lung cancer research

Published: September 08, 2022

Impact of coronavirus of 2019 on the delivery of pharmacy services to patients with cancer: An international survey of oncology pharmacy practitioners.

Impact of coronavirus of 2019 on the delivery of pharmacy services to patients with cancer: An international survey of oncology pharmacy practitioners.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: October 25, 2021

Impact of COVID-19 on cancer service delivery: a follow-up international survey of oncology clinicians.

Impact of COVID-19 on cancer service delivery: a follow-up international survey of oncology clinicians.

Journal: ESMO open

Published: May 27, 2021

Beyond cabazitaxel: Late line treatments in metastatic castration resistant prostate cancer: A retrospective multicentre analysis.

Beyond cabazitaxel: Late line treatments in metastatic castration resistant prostate cancer: A retrospective multicentre analysis.

Journal: Asia-Pacific journal of clinical oncology

Published: May 16, 2021

Complete metabolic response following anaplastic lymphoma kinase (ALK) targeted therapy in a patient with adenocarcinoma of unknown primary with immunohistochemistry/fluorescence in situ hybridisation discordant ALK test results.

Complete metabolic response following anaplastic lymphoma kinase (ALK) targeted therapy in a patient with adenocarcinoma of unknown primary with immunohistochemistry/fluorescence in situ hybridisation discordant ALK test results.

Journal: Internal medicine journal

Published: October 04, 2020

Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians.

Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians.

Journal: ESMO open

Published: September 30, 2020

Pilot Study of Patients' Preferences for Immediate Resection Versus a Watch and Wait Approach After Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer.

Pilot Study of Patients' Preferences for Immediate Resection Versus a Watch and Wait Approach After Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer.

Journal: JCO oncology practice

Published: September 14, 2020

Global oncology pharmacy response to COVID-19 pandemic: Medication access and safety.

Global oncology pharmacy response to COVID-19 pandemic: Medication access and safety.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: May 16, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026